Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04591678 · ClinicalTrials.gov registry record
Adults With SMA Treated With Nusinersen
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 15
- Enrollment target
NCT04591678 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 15 participants.
The verdict
NCT04591678 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
This is a single center, 22-month observational study of nusinersen treatment in adult patients with spinal muscular atrophy (SMA). There will be a total of seven visits. Nusinersen is provided as standard of care and not considered research in this study. Information will be collected regarding the general health, and function including muscle strength of, as well as any positive and/or adverse events experienced by the study participants.
Interventions
- DRUG nusinersen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2021-06-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04591678
The ClinicalTrials.gov registry entry for NCT04591678 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which nusinersen is the first listed.
NCT04591678 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04591678 about?
NCT04591678 is a clinical study titled "Adults With SMA Treated With Nusinersen". This is a single center, 22-month observational study of nusinersen treatment in adult patients with spinal muscular atrophy (SMA). There will be a total of seven visits. Nusinersen is provided as standard of care and not considered research in this study. Information will be collected regarding the...
What is the current status of trial NCT04591678?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2018-10-01. Estimated completion is 2021-06-25.
What interventions are being tested in trial NCT04591678?
The interventions under investigation include: nusinersen (DRUG).
Who is sponsoring clinical trial NCT04591678?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.